Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Graduate Institute of Medical Sciences / 醫學科學研究所
  4. Anti-angiogenic action of 5; 5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).
 
  • Details
Options

Anti-angiogenic action of 5; 5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).

Type
article
Resource
Cancer Letters.(271):294-305.
Date Issued
2008
Author(s)
李文森
Liu Y; Wu J; Ho PY; Chen LC; Chen JT; Liang YC; Cheng CK; Lee WS
Subjects
醫學科學研究所
期刊論文
Abstract
Previously, we demonstrated that 5,5-diphenyl-2-thiohydantoin (DPTH) exerts an anti-proliferation effect on subcultured human umbilical vein endothelial cells (HUVEC). In the present study, we show that 2(naphthalen-2-ylmethylsulfanyl)-5,5-diphenyl-1,5-dihydro-imidazol-4-one (DPTH-N10), a derivative compound of DPTH, exerts a 5 times stronger inhibition of [3H]thymidine incorporation into HUVEC as compared with DPTH and at very low concentrations (0–20 μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a concentration- and time-dependent manner, but not in human fibroblasts. [3H]thymidine incorporation analysis demonstrated that treatment of HUVEC with DPTH-N10 arrested the cell at the G0/G1 phase of the cell cycle. Western blot analysis revealed that the protein level of p21 in HUVEC increased after DPTH-N10 treatment. In contrast, the protein levels of p27, p53, cyclins A, D1, D3 and E, cyclin-dependent kinase (CDK)2, and CDK4 in HUVEC were not changed significantly after DPTH-N10 treatment. Immunoprecipitation showed that the formation of the CDK2–p21 complex, but not the CDK2–p27, CDK4–p21, and CDK4–p27 complex, was increased in the DPTH-N10-treated HUVEC. Kinase assay further demonstrated that CDK2, but not CDK4, kinase activity was decreased in the DPTH-N10-treated HUVEC. Pretreatment of HUVEC with a p21, but not p27, antisense oligonucleotide reversed the DPTH-N10-induced inhibition of [3H]thymidine incorporation into HUVEC. Taken together, these data suggest that DPTH-N10 inhibits HUVEC proliferation by increasing the level of p21 protein, which in turn inhibits CDK2 kinase activity, and finally interrupts the cell cycle. Capillary-like tube formation, aortic ring culture, and chick embryo chorioallantoic membrane (CAM) assays further demonstrated the anti-angiogenic effect of DPTH-N10.

Keywords: Angiogenesis; p21; Proliferation; Endothelial cells; Cyclin-dependent kinase

Abbreviations: DPTH-N10, 5,5-diphenyl-2-thiohydantoin-N10; DPT, 5,5-diphenylhydantoin; HUVEC, human umbilical vein endothelial cells; CDK, cyclin-dependent kinase; CAM, chick embryo chorioallantoic membrane; SDS, sodium dodecyl sulfate; ECGS, endothelial cell growth supplement; M199, medium 199; FBS, fetal bovine serum; CKI, CDK-inhibitory protein; FACS, fluorescence-activated cell sorter
URI
https://203.71.86.71/handle/123456789/34142
File(s)
Loading...
Thumbnail Image
Name

attachment.pdf

Size

598.65 KB

Format

Adobe PDF

Checksum

(MD5):57a730ba46b1366ae41d12d44cd7a781

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback